Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both Eyes
about
Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both Eyes
description
clinical trial
@en
klinisch onderzoek
@nl
name
Bioequivalence Study With Clin ...... ular Hypertension in Both Eyes
@en
Bioequivalence Study With Clin ...... ular Hypertension in Both Eyes
@nl
type
label
Bioequivalence Study With Clin ...... ular Hypertension in Both Eyes
@en
Bioequivalence Study With Clin ...... ular Hypertension in Both Eyes
@nl
prefLabel
Bioequivalence Study With Clin ...... ular Hypertension in Both Eyes
@en
Bioequivalence Study With Clin ...... ular Hypertension in Both Eyes
@nl
P1050
P1132
P1476
A Multicentre, Double Blind, A ...... ular Hypertension in Both Eyes
@en
P3098
NCT02512042
P4844
P580
2015-04-01T00:00:00Z
P582
2016-04-01T00:00:00Z